Invesaro

Stocks VSXY Financial statements

Financial statements

Victoria's Secret & Co. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Victoria's Secret & Co. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2021FY2021FY2022FY2023FY2024FY2025
Revenue7,5095,4136,7856,3446,1826,2306,553
Cost of revenue5,4463,8424,0254,0863,9403,9464,169
Gross profit2,0631,5712,7602,2582,2422,2842,384
Selling, general and administrative2,2351,6721,8901,7801,9961,9742,113
Operating income-892-101870478246310271
Interest expense862760998670
Other non-operating income110-10-37
Pre-tax income-899-106843417147221208
Income tax-2-3419779315219
Net income to minority interests00-107428
Net income-897-72646348109165161
EBITDA-4812251,173752530568509
EPS, basic-10.16-0.827.344.241.412.112.00
EPS, diluted-10.16-0.827.184.141.392.051.93
Shares, basic (weighted)88888882787980
Shares, diluted (weighted)88889084798183

Balance sheet

FY2021FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents245335490427270227518
Receivables121162141152159186
Inventory7019491,0529859551,071
Other current assets8290117126100108
Total current assets1,2391,6911,7371,5331,4411,883
Property, plant and equipment1,078957846843774731
Lease right-of-use assets1,5901,3691,2321,3511,4811,631
Goodwill0365367367367
Intangible assets180155130
Other non-current assets566487867190
Total assets4,2294,3444,7114,6004,5325,013
Accounts payable338538481513419493
Accrued liabilities782714737810633673
Short-term debt044444
Total current liabilities1,5561,6981,5791,6141,3751,507
Long-term debt979781,2711,120973971
Lease liabilities1,5531,3141,2011,3121,4341,576
Other non-current liabilities11339206797544
Total liabilities3,3384,0874,3104,1623,8684,103
Total debt979821,2751,124977975
Paid-in capital0125195238297345
Retained earnings0126186178343504
Treasury stock00
Other comprehensive income-294510-16
Shareholders' equity891257383417640856
Minority interests0018212454
Total equity1,314891257401438664910
Total liabilities and equity4,2294,3444,7114,6004,5325,013
Shares outstanding08580787980

Cash flow statement

FY2021FY2021FY2021FY2022FY2023FY2024FY2025
Net income-897-72646338116169189
Depreciation and amortization411326303274284258238
Stock-based compensation38253348566055
Deferred income tax-30-641-28-16-29-49
Change in receivables1436-2122-13-8-24
Change in inventory20141-24703629-112
Change in payables-11849173-163-11-78114
Cash from operations315674851437389425499
Capital expenditures-225-127-169-164-256-178-187
Acquisitions00-369100
Cash from investing-243-123-169-555-254-153-184
Debt repaid00-1-4-4-4-4
Stock issued0055354
Share buybacks00-250-250-12500
Cash from financing-192-465-52758-291-315-24
Exchange rate effect-440-3-100
Net change in cash-12490155-63-157-43291
Free cash flow90547682273133247312
Interest paid01852877766
Income taxes paid1155956161745487

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $82.91 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin39.6%Gross profit / revenue.
Operating margin7.9%Operating income / revenue.
EBITDA margin10.9%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin5.5%Net income / revenue.
FCF margin8.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin11.0%Cash from operations / revenue.
Return on equity (ROE)38.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)7.3%Net income / average total assets.
Return on invested capital (ROIC)29.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue31.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.0%Capital expenditures / revenue.
D&A / revenue3.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y3.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y4.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-12.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-17.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y-10.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-12.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y17.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-2.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-22.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y-5.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-22.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y17.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y4.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-5.8%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y26.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y4.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-10.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y33.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y30.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-0.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y10.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y2.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.36xCurrent assets / current liabilities.
Quick ratio0.48x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.36x(Cash + short-term investments) / current liabilities.
Debt / equity0.98xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets18.9%Total debt / total assets.
Liabilities / assets79.6%Total liabilities / total assets.
Net debt$453.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.60xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage8.35xOperating income / interest expense.
Working capital$519.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets7.1%(Goodwill + intangible assets) / total assets.
Tangible book value$623.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.34xRevenue / average total assets.
Fixed asset turnover9.09xRevenue / average property, plant and equipment.
Inventory turnover3.62xCost of revenue / average inventory.
Days inventory101 days365 x average inventory / cost of revenue.
Receivables turnover40.4xRevenue / average receivables.
Days sales outstanding9 days365 x average receivables / revenue.
Days payables43 days365 x average accounts payable / cost of revenue.
Cash conversion cycle67 daysDays inventory + days sales outstanding - days payables.
FCF conversion146.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow26.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$4.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$82.29Revenue / diluted weighted shares.
FCF per share$6.60Free cash flow / diluted weighted shares.
Operating cash flow per share$9.02Cash from operations / diluted weighted shares.
Book value per share$12.38Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$7.79Tangible book value / shares outstanding.
Cash per share$6.53(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$6.59BShare price x shares outstanding.
Enterprise value$7.04BMarket cap + total debt - cash - short-term investments.
P/E17.4xMarket cap / net income. Only when net income is positive.
P/S0.95xMarket cap / revenue.
P/B6.66xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book10.6xMarket cap / tangible book value, when positive.
P/FCF11.9xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.69xMarket cap / cash from operations, when positive.
EV/Sales1.02xEnterprise value / revenue.
EV/EBIT13.0xEnterprise value / operating income, when both are positive.
EV/EBITDA9.39xEnterprise value / EBITDA, when both are positive.
EV/FCF12.7xEnterprise value / free cash flow, when both are positive.
FCF yield8.4%Free cash flow / market cap.
Earnings yield5.7%Net income / market cap (the inverse of P/E).
What was Victoria's Secret & Co.'s revenue in fiscal 2025?

Victoria's Secret & Co. reported revenue of $6.55B for fiscal 2025, 5.2% higher than the year before.

Was Victoria's Secret & Co. profitable in fiscal 2025?

Yes. Net income was $161.0M, a net margin of 2.5%.

How much free cash flow did Victoria's Secret & Co. generate in fiscal 2025?

Cash from operations of $499.0M minus capital expenditures of $187.0M left free cash flow of $312.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Victoria's Secret & Co.